<DOC>
	<DOCNO>NCT01827319</DOCNO>
	<brief_summary>The objective registry follow : - Track `` real world '' performance outcome physician experience use Cardiogenesis Laser System ; - Further define disease characteristic population treat ; - Examine transmyocardial revascularization ( TMR ) usage characteristic 30-day outcome ; - Further assess 30-day postoperative risk factor adverse event . To limit potential bias , patient eligible TMR treatment meet Inclusion Exclusion Criteria offer opportunity enroll study participate center .</brief_summary>
	<brief_title>Cardiogenesis Transmyocardial Revascularization Registry</brief_title>
	<detailed_description>The objective patient registry , collect data Cardiogenesis Laser System , include : provide information disease characteristic population treat , examine TMR usage characteristic , monitor 30-day postoperative mortality MACE rate , assess preoperative operative risk factor adverse event . To limit potential bias , patient eligible TMR treatment meet Inclusion Exclusion Criteria offer opportunity enroll study participate center . Patient consent indicate approval allow collection confidential data ; nonetheless , identity disclose publication study . The primary endpoint assess study : • All-cause 30-day mortality Additional endpoint assess study : • Major adverse cardiovascular event ( MACE ) rate , define incidence cardiac-related death , myocardial infarction ( Q-wave non Q-wave ) , congestive heart failure , cerebrovascular accident , serious arrhythmia 30-day postoperative period . The definition event follow : Cardiac-related death : death clearly attributable non-cardiac cause include death due following : acute myocardial infarction , heart failure , cardiogenic shock , pulmonary edema , cardiac tamponade , arrhythmia , post-procedural complication ( i.e. , bleed ) . Q-wave myocardial infarction : appearance new Q wave 40 millisecond 2 contiguous lead elevation CK-MB . Non Q-wave myocardial infarction : elevation total CK twice normal elevated CK-MB . Congestive heart failure : Symptoms pulmonary vascular congestion low output state due leave ventricular failure new onset result re-hospitalization . Cerebrovascular accident : Any sudden development neurological deficit due vascular lesion brain hemorrhage , embolism , thrombosis persists &gt; 24 hour . Serious arrhythmia : Supraventricular ventricular arrhythmia require sustain intravenous pharmacologic treatment , temporary permanent pacing , immediate electrical cardioversion defibrillation . Arrhythmias result syncope , myocardial ischemia , death also classify serious . Any serious operative complication related procedure : example : major bleed require transfusion . Each contribute site require complete Enrollment Failure Log Form patient undergo TMR , enrol registry due inclusion/exclusion criterion failure consent registry participation . If decision perform TMR do intra-operatively , patient approach participation registry procedure . No data collect prior patient consent take part registry . All data collect must support source document find site . Patient medical record , hospital chart , operative report , laboratory diagnostic testing result , office visit , source document worksheet supply Sponsor , etc . utilized collection relevant data . All data subject 100 % source document review Sponsor personnel and/or representative Sponsor Sponsor 's discretion .</detailed_description>
	<mesh_term>Angina Pectoris</mesh_term>
	<criteria>Class IV angina ( accord Canadian Cardiovascular Society Angina Scale ) Patients region myocardium distal twothirds leave ventricle reversible ischemia eligible direct coronary revascularization ( e.g. , CABG PTCA ) Age less than18 year Severely unstable angina ( unweanable intravenous antianginals 48hours )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Angina</keyword>
	<keyword>Transmyocardial revascularization</keyword>
</DOC>